Neuroradiology Departments, Azienda Ospedaliera Universitaria Integrata Verona, Ospedale Civile Maggiore, Borgo Trento, Verona, Italy.
Neuroradiology Departments, Azienda Ospedaliera Universitaria Integrata Verona, Ospedale Civile Maggiore, Borgo Trento, Verona, Italy.
Eur J Radiol. 2019 Jul;116:174-179. doi: 10.1016/j.ejrad.2019.04.020. Epub 2019 May 7.
To evaluate any possible correlation between the presence of Isocitrate DeHydrogenase 1 mutation (IDH1m) and specific DTI (Diffusion Tensor Imaging) metrics, such as Fractional Anisotropy (FA), Mean Diffusivity (MD), Radial Diffusivity (RD) and Axial Diffusivity (AD).
We retrospectively analyzed 47 patients who underwent an advanced-MR study with DTI followed by surgical intervention with a subsequent histologic diagnosis of High-Grade Glioma (HGG) and immunohistochemical evaluation of IDH1 (Isocitrate DeHydrogenase) mutation status. For each DTI metrics we measured the ratio between tumor and normal tissue and we evaluated the correlation with IDH1 mutation.
We observed a positive correlation with IDH1 status and RD and MD data. No correlation was demonstrated between IDH1 status and FA and AD.
Our results support the hypothesis that the number of residual axonal fibers, extracellular matrix composition and the presence of colliquated tissue, may together contribute to a global RD increase in HGG, with a relatively higher increase in IDH1m tumors.
Our data are in favor of a need for multimodal advance evaluation of HGG. DTI metrics help to analyze IDH1 mutation status, in order to better characterize the lesions and to tailor treatment and follow up.
评估异柠檬酸脱氢酶 1 突变(IDH1m)的存在与特定的弥散张量成像(DTI)指标(如各向异性分数(FA)、平均弥散度(MD)、径向弥散度(RD)和轴向弥散度(AD))之间是否存在相关性。
我们回顾性分析了 47 例接受高级磁共振研究(包括 DTI)并随后进行手术干预的患者,这些患者的组织学诊断为高级别胶质瘤(HGG),并对 IDH1(异柠檬酸脱氢酶)突变状态进行了免疫组织化学评估。对于每个 DTI 指标,我们测量了肿瘤和正常组织之间的比值,并评估了与 IDH1 突变的相关性。
我们观察到 IDH1 状态与 RD 和 MD 数据之间存在正相关。IDH1 状态与 FA 和 AD 之间没有相关性。
我们的结果支持以下假设:残留轴突纤维的数量、细胞外基质组成以及液化组织的存在,可能共同导致 HGG 中 RD 的整体增加,而 IDH1m 肿瘤的增加相对较高。
我们的数据支持对 HGG 进行多模态高级评估的需要。DTI 指标有助于分析 IDH1 突变状态,以更好地对病变进行特征描述,并为治疗和随访提供依据。